stem cell therapy for spinal cord injury (SCI) is a life-changing condition that affects hundreds of thousands of people in the United States. Each year, approximately 17,000 new cases are reported, and more than 290,000 individuals are living with long-term effects. Damage to the spinal cord can lead to partial or complete loss of movement…
Mesenchymal stromal cell therapy, often called contact Stemedix to learn about your options, has become one of the most widely studied approaches in regenerative and cellular medicine. Over the past two decades, researchers have explored its potential to treat a wide range of inflammatory and immune-related conditions, including heart disease, lung injury, autoimmune disorders, and…
Mesenchymal stromal stem cells, commonly called MSCs, have been among the most-studied cell types in regenerative medicine over the past two decades. They have been tested in hundreds of clinical trials for conditions ranging from joint degeneration to heart disease, autoimmune disorders, lung injury, and complications after transplantation. MSCs have consistently been shown to be…
Autoimmune and rheumatic diseases affect millions of people worldwide and can involve the joints, skin, gut, nervous system, and many other organs. Conditions like regenerative medicine for rheumatoid arthritis, stem cell therapy for osteoarthritis, lupus, stem cell therapy for inflammatory bowel disease disease, stem cell therapy for multiple sclerosis, and Sjögren’s syndrome often cause regenerative…
Low back pain is one of the most common health problems worldwide. It affects quality of life, limits work and daily activities, and creates a significant economic burden. In many adults, especially those over age 50, a key driver of this pain is lumbar intervertebral disc degeneration. When the disc between the vertebrae begins to…
Aging is a universal biological process marked by the gradual decline of physiological function across all organ systems. It is driven by a combination of genetic, environmental, and molecular factors that influence the rate of deterioration from birth onward. Although inevitable, scientific progress in regenerative medicine has identified potential ways to mitigate its effects and…
Mesenchymal stem cells (MSCs) are at the forefront of regenerative medicine, offering significant therapeutic potential due to their self-renewal, multipotency, and immunomodulatory properties. These nonhematopoietic adult stem cells can differentiate into various mesodermal lineages, including bone, cartilage, and adipose cells, while influencing immune and inflammatory pathways. As part of this review, Han et al. explore…
Alzheimer’s disease (AD) is the most common cause of dementia, gradually destroying memory, learning, and functional independence. Current FDA-approved drugs such as donepezil, rivastigmine, galantamine, and memantine provide limited symptomatic relief but do not slow the progression of neuronal loss. Antibody therapies that target amyloid plaques have shown inconsistent regenerative medicine for neurodegenerative conditions outcomes.…
stem cell therapy for Parkinson disease’s disease (PD) is one of the most common neurodegenerative conditions, second only to Alzheimer’s. It primarily affects the basal nuclei of the brain, leading to the gradual loss of dopamine-producing neurons and the buildup of abnormal protein clusters called Lewy bodies. Together, these changes cause the classic motor and…
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease that causes irreversible damage to the alveoli and leads to pulmonary interstitial fibrosis. stem cell therapy for lung disease with IPF often experience severe difficulty breathing, which can result in respiratory failure and death. The disease is challenging to diagnose, has a high mortality rate,…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!